SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) -- Ignore unavailable to you. Want to Upgrade?

To: idahoranch1 who wrote (308)12/21/2004 6:01:26 PM
From: kitty2  Read Replies (1) | Respond to of 371
 
idaho1
can immu get straight into phase3 for lupus with 17 treated patients in germany and if so how?
they would need a partner to fund phase 3 right?
If no partner no phase 3 right?
So it really all comes down to one issue that must occur at least in the first half of the year actually first qtr and that is get a big pharma partner



To: idahoranch1 who wrote (308)12/21/2004 8:28:56 PM
From: Cormac_Wright  Respond to of 371
 
Thanks Idaho.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News